Akebia Therapeutics · 1 day ago
Associate Director, Commercial Training & Field Effectiveness
Akebia Therapeutics is dedicated to improving the lives of individuals impacted by Chronic Kidney Disease. The Associate Director of Field Engagement and Effectiveness will be responsible for developing and delivering training programs for customer-facing roles, while also gathering insights to enhance field effectiveness and collaborating across multiple departments.
BiotechnologyHealth CareTherapeutics
Responsibilities
Aligning to Akebia’s annual strategy for sales and marketing focus
Develop a sales training curriculum that motivates customer-facing personnel to achieve their goals and align with the strategy
Establish a collaborative, clinical, sales focused learning environment with core principles of adult learning
Optimize curriculum that allows ongoing education for customer-facing teams to ensure consistency in disease state and product knowledge. (product/non-product training modules)
Lead and coordinate new hire onboarding and training programs for customer-facing teams
Collaborate with Subject Matter Experts (SMEs) to create the appropriate learning content for the respective customer-facing role
Direct Field Trainers who will be peer-to-peer trainers with their colleagues within the sales team
Liaise with home office/field management about the development and delivery of training material
Document and maintain proper records of training initiatives
Collaborate with the administration of the Promotional, Medical, Legal, & Regulatory (PRC) process to identify the training requirements and the delivery of material for use
Support efforts in Company meeting planning and execution, including agenda creation, workshop development, and delivery as well as overall meeting facilitation for POAs & NSMs
Manage vendors and partners to produce meaningful curriculum within established scope and timeframes
Perform additional responsibilities and participate in special projects as assigned
Work with Sales Leadership Team to review team effectiveness with the aim of identifying performance gaps and create sales tactics and/or training programs to address them
Interpret sales data and KAM call information to develop appropriate training reinforcement and development plans
Perform ride along with KAMs to provide feedback on promotional effectiveness, customer engagement and territory management
Develop and implement KAM feedback tool to provide written feedback to KAMs to highlight performance attributes affecting promotional success
Develop and manage feedback from sales organization on key initiatives
Manage Learning Management System (Akebia Learning) partnering closely with Compliance, Commercial and Human Resources
Participate in the implementation/deployment of technologies (Veeva CRM, Sales portal) to be used by the field force to increase efficiency, and effectiveness and determine the best way to train the team
Qualification
Required
Bachelor's degree required
8+ years' experience in a commercial role within a pharma or biotech company and at least 5 years in a sales/product training-focused role
Previous Experience in building a sales training continuum for a life science company
Proficient in Microsoft Office Suite, including PowerPoint, Excel, and Word
Proficient in sales reporting and analytics tools (e.g., Tableau), as well as CRM and Learning Management Systems (LMS)
Demonstrated experience with best-in-class means of training delivery including eLearning, self-study, assessment, audio/video, classroom, and experiential learning to ensure the sales force is trained and can deliver the attributes of our products
Strong interpersonal, presentation and facilitation skills required
Demonstrated success in managing numerous projects simultaneously
Ability to challenge the thinking of an established customer facing team
Requires 15-35% travel
Preferred
Previous field sales experience is strongly preferred
Benefits
Health care
Vision
Dental
Retirement
PTO
Company
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Funding
Current Stage
Public CompanyTotal Funding
$442.5M2024-01-30Post Ipo Debt· $37M
2020-05-11Post Ipo Equity· $151.8M
2019-11-12Post Ipo Debt· $100M
Recent News
MarketScreener
2026-01-06
2026-01-06
Company data provided by crunchbase